Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6afda0a5004b9952b06a00e6",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Etifoxine Hydrochloride Capsules 50 mg",
"description": "ETHICILLIN 50 is a prescription capsule that contains 50 mg of Etifoxine Hydrochloride. Doctors use it to treat the physical symptoms that come with anxiety (psychosomatic manifestations), in line with the approved prescribing information. It should only be taken under the guidance of a qualified healthcare professional.\n\nAnxiety affects more than mood. People may notice constant worry, nervousness, a feeling of being on edge, restlessness, and bodily discomfort. A proper medical assessment helps decide the right way to manage these symptoms and support day-to-day well-being.\n\nEtifoxine Hydrochloride is an anxiolytic from the benzoxazine chemical class. It acts on the brain’s GABA signalling pathways, which help regulate how active the nervous system is.\n\nComposition and Product Details\nDetail\tInformation\nBrand Name\tETHICILLIN 50\nActive Ingredient\tEtifoxine Hydrochloride\nStrength\t50 mg per capsule\nDosage Form\tHard gelatin capsule\nCategory\tAnxiolytic\nAvailability\tPrescription only\nAbout Etifoxine Hydrochloride\n\nEtifoxine is an anti-anxiety medicine that works on pathways controlling nervous system activity. It is linked to the GABA-A receptor system, which keeps a healthy balance between the brain’s “go” and “slow down” signals.\n\nGABA (gamma-aminobutyric acid) is the brain’s main calming neurotransmitter, and it helps keep nerve cell firing in check. Research has looked at two ways Etifoxine acts:\n\nIt interacts directly with certain GABA-A receptor subunits.\nIt influences the production of neurosteroids, which in turn affect GABA signalling.\n\nTogether, these actions strengthen inhibitory signalling in the brain and give Etifoxine its anti-anxiety effect.\n\nWhat ETHICILLIN 50 Is Used For\n\nETHICILLIN 50 is meant for the physical and emotional symptoms of anxiety, as covered by its approved indications. These can include:\n\nOngoing worry or nervousness\nInner tension and restlessness\nTrouble coping with stressful situations\nBodily discomfort linked to anxiety\nUnease that interferes with everyday activities\n\nHow strong these symptoms are differs from one person to the next, so a doctor should evaluate the patient before recommending any treatment.\n\nPrescription only – consult your doctor.\n\nHow It Works\n\nEtifoxine Hydrochloride acts on the brain’s GABA-related pathways. GABA reduces excessive nerve activity and supports steady communication between brain cells. By interacting with GABA-A receptors and promoting neurosteroid production, Etifoxine helps produce a calming effect.\n\nIndividual response varies and depends on medical history, the type of symptoms and other health factors.\n\nKey Features\nEstablished active ingredient: Etifoxine Hydrochloride, an anxiolytic studied for its effect on GABA pathways.\nCapsule form: An oral dosage form taken as the doctor directs.\nDefined strength: 50 mg of active ingredient in each capsule.\nPrescription-based use: A doctor can consider it when choosing a treatment for psychosomatic symptoms of anxiety.\nClear composition: A clearly identified formulation that supports professional prescribing and patient management.\nDosage and Administration\n\nYour doctor decides the dose and length of treatment based on your condition, medical history and needs. Swallow the capsule with water as instructed.\n\nTake it exactly as prescribed.\nDo not raise, lower or stop the dose without speaking to your doctor.\nNever share it with anyone else, even if their symptoms look similar.\nPrecautions and Safety Information\n\nBefore you start, tell your doctor about your medical history, any existing conditions, allergies and all the medicines you currently take.\n\nLiver and kidney problems: Extra medical evaluation is needed.\nRare but serious reactions: Etifoxine has been linked to severe liver injury and serious skin reactions. Get medical help immediately if you notice yellowing of the skin or eyes, dark urine or unusual tiredness (possible liver problems), or a widespread rash, blistering or swelling (possible serious skin reaction).\nPrevious reactions: Do not use it if you have ever had a severe liver or skin reaction linked to Etifoxine.\nPregnancy and breastfeeding: Speak to your doctor before considering this medicine.\n\nFor full details on contraindications, side effects, interactions and warnings, see the approved prescribing information.\n\nWhy Choose ETHICILLIN 50?\n\nETHICILLIN 50 offers Etifoxine Hydrochloride 50 mg in a clearly defined capsule, giving doctors a straightforward option to consider for prescription-based anxiety management. Any medicine choice should follow a proper medical assessment that takes in symptoms, overall health, history and response to treatment.\n\nConclusion\n\nETHICILLIN 50 (Etifoxine Hydrochloride Capsules 50 mg) contains an established anxiolytic ingredient for managing the physical symptoms of anxiety. Knowing what it contains, how it works, what it is approved for and which precautions apply helps you use it responsibly. Always follow your healthcare professional’s advice and read the approved product information before starting.\n\nPrescription only – consult your doctor.\n\nFrequently Asked Questions\n\nQ1. What is ETHICILLIN 50?\nIt is a capsule containing 50 mg of Etifoxine Hydrochloride, prescribed for the physical symptoms of anxiety in line with its approved prescribing information.\n\nQ2. What does each ETHICILLIN 50 capsule contain?\nEach capsule holds 50 mg of Etifoxine Hydrochloride as the active ingredient.\n\nQ3. What is Etifoxine Hydrochloride used for?\nIt is an anti-anxiety agent used under medical supervision to manage the psychosomatic symptoms of anxiety.\n\nQ4. How do I take ETHICILLIN 50?\nTake it exactly as your doctor prescribes, for the length of time they advise.\n\nQ5. Do I need a prescription for ETHICILLIN 50?\nYes. Use it only under the guidance of a qualified medical practitioner.\n\nQ6. Can ETHICILLIN 50 cause side effects?\nLike any medicine, it can. Rare but serious liver and skin reactions have been reported with Etifoxine, so speak to your healthcare professional for complete safety information.",
"price": 265.0,
"discountamount": 79.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2519,
"imageuri": "https://productimages.withfloats.com/actual/6afda0ae246f00294793aa6e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6afda0ae246f00294793aa6e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-11-18T12:57:09.742Z",
"updatedon": "2026-11-18T12:57:09.742Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/etifoxine-hydrochloride-capsules-50-mg/2519",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ETHICILLIN 50",
"category": "NEUROLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6afd8688f26739925f1e90be",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tropicamide and phenylephrine hydrochloride ophthalmic solution",
"description": "Product Overview\n\nCIPVISION TRACOPA PLUS is a dual-ingredient mydriatic eye drop containing Tropicamide and Phenylephrine Hydrochloride. It is made for ophthalmologists who need a dilated pupil during eye examinations, retinal imaging or preparation for eye procedures.\n\nThe two drugs enlarge the pupil by different routes. Together they give the examiner a wider, clearer window into the eye, which supports accurate diagnosis and treatment planning.\n\nComposition\n\nEach ingredient plays a distinct role.\n\n1. Tropicamide (anticholinergic)\nTropicamide blocks muscarinic receptors in the eye. This relaxes the sphincter muscle that normally narrows the pupil, so the pupil opens up. It can also briefly weaken the eye’s focusing ability, which makes near vision blurry for a while.\n\n2. Phenylephrine Hydrochloride (alpha-adrenergic agonist)\nPhenylephrine activates alpha-1 receptors on the iris dilator muscle. The muscle tightens and pulls the pupil wider.\n\nWorking together: One drug eases the muscle that closes the pupil and the other stimulates the muscle that opens it. Using both is a common way for eye specialists to get dilation when an examination or procedure calls for it.\n\nWhat Is It Used For?\n\nEye care professionals use CIPVISION TRACOPA PLUS when a widened pupil is needed for assessment or treatment preparation. Typical uses include:\n\nRoutine eye examinations: gives a broader view of the eye’s internal structures.\nFundus examination: allows inspection of the retina, optic disc and other posterior structures.\nRetinal evaluation: supports detailed viewing during targeted retinal investigations.\nDiagnostic eye tests: readies the eye for tests that need an enlarged pupil.\nPre-procedure preparation: may be given before certain ophthalmic procedures when the clinician considers it appropriate.\nHow Tropicamide and Phenylephrine Eye Drops Work\n\nTropicamide’s role: It blocks muscarinic receptors in the iris sphincter. With that muscle’s constricting action switched off for a time, the pupil widens. Because focusing is also affected, close-up vision may be difficult during this period.\n\nPhenylephrine’s role: It stimulates alpha-1 adrenergic receptors in the iris dilator. The muscle contracts and the pupil diameter increases.\n\nWhy combine them? The two drugs target opposite muscle systems that control pupil size. Their separate effects add up, which helps achieve dilation for diagnostic and procedural needs.\n\nKey Features\nContains Tropicamide and Phenylephrine Hydrochloride\nPairs two well-established ophthalmic agents\nMade for pupil dilation in clinical eye care\nSupports fundus and retinal examinations\nImproves visibility of deeper eye structures during diagnosis\nFor selected clinical uses under professional supervision\nPart of the CIPVISION ophthalmic range from Steris Pharma\nBenefits of Tropicamide and Phenylephrine Eye Drops\n\nWhen prescribed and used correctly, this combination offers several practical advantages in the clinic.\n\n1. Effective pupil enlargement\nTwo active ingredients acting on different receptors help open the pupil for examinations that require it.\n\n2. Clearer internal eye assessment\nA wider pupil gives the doctor a larger field of view, so important structures are easier to evaluate.\n\n3. Better retinal access\nDilation improves the view of the retina, optic nerve and back of the eye.\n\n4. Dual-pathway pharmacology\nBecause the drugs act on separate receptors, they provide complementary support for dilation.\n\n5. Helpful in select procedures\nIt can be part of preparation for procedures requiring mydriasis, as decided by the treating ophthalmologist.\n\nPossible Side Effects\n\nAs with other dilating eye drops, some short-lived effects may follow instillation:\n\nBlurred vision for a time\nGreater sensitivity to light\nMild stinging or burning on application\nTemporary eye discomfort\nTrouble focusing on near objects\nShort-term redness or irritation\nPrecautions and Safety Advice\n\nA proper medical evaluation should come before using these drops.\n\nUse only as prescribed and instructed by your ophthalmologist.\nTell your doctor about any eye condition, especially narrow-angle glaucoma or a tendency toward angle closure.\nMention any heart disease, high blood pressure or other relevant health issues.\nList every medicine you use, including other eye drops.\nExpect blurred vision and light sensitivity for some time after the drops.\nDo not drive, cycle or run machinery until your vision is back to normal.\nKeep the dropper tip away from your eye, fingers and any surface to avoid contamination.\nClose the bottle tightly after use.\nFollow the storage and handling directions on the pack.\nKeep out of reach of children.\nHow It Is Used\n\nCIPVISION TRACOPA PLUS is meant to be administered by an ophthalmologist or other qualified healthcare professional, depending on the clinical purpose. The number of drops, the interval between them and the timing of the examination depend on the patient’s age, eye condition and medical needs.\n\nWhy Choose Steris Pharma?\n\nSteris Pharma supplies pharmaceutical products that respond to the changing needs of healthcare professionals and the wider industry. Its CIPVISION ophthalmic range offers formulations for a variety of eye care needs, built around established active ingredients and their clinical uses.\n\nCIPVISION TRACOPA PLUS belongs to this range and brings Tropicamide and Phenylephrine Hydrochloride together for professional pupil dilation.\n\nConclusion\n\nCIPVISION TRACOPA PLUS is a combination eye drop of Tropicamide and Phenylephrine Hydrochloride, intended to dilate the pupil during selected eye examinations and procedures. Tropicamide eases the muscle that narrows the pupil, while Phenylephrine stimulates the muscle that widens it. Together they help ophthalmolog",
"price": 90.0,
"discountamount": 27.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2515,
"imageuri": "https://productimages.withfloats.com/actual/6afd868b4954e0b067f47757.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6afd868b4954e0b067f47757.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-11-18T11:05:44.104Z",
"updatedon": "2026-11-18T11:05:44.104Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tropicamide-and-phenylephrine-hydrochloride-ophthalmic-solution/2515",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION TRACOPA PLUS",
"category": "Opthalmology Range",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6afd8125907a69858e813c04",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Ondansetron 8 mg Orally Disintegrating Tablets IP",
"description": "ONDEFILM 8 DT is a prescription anti-sickness tablet with Ondansetron IP 8 mg per dose. It is meant for people who need protection from persistent nausea and vomiting caused by certain therapies or procedures. Because it is an orally disintegrating tablet, it melts on the tongue and does not need to be swallowed whole, which helps patients who find ordinary tablets hard to take. The medicine should be used only as directed by a qualified doctor.\n\nOndansetron is a 5-HT3 receptor antagonist. It stops serotonin from triggering the signals that set off the urge to vomit.\n\nComposition\n\nEach tablet contains:\n\nOndansetron IP: 8 mg\nExcipients: as per the approved formulation\nUnderstanding the Active Ingredient\n\nOndansetron is a well-established antiemetic. Doctors commonly use it for nausea and vomiting linked to cancer chemotherapy, radiotherapy and surgery. It interrupts the chemical messaging that tells the body to vomit.\n\nUses of ONDEFILM 8 DT\n\nYour doctor may prescribe this tablet in the following situations. The exact indication, dose and duration are always the doctor’s decision.\n\n1. Chemotherapy-induced nausea and vomiting\nMany anticancer drugs prompt the release of serotonin in the gut, which sets off sickness. Ondansetron blocks this pathway and is usually given as one component of a wider antiemetic plan.\n\n2. Radiotherapy-related nausea and vomiting\nRadiation aimed at certain parts of the body can upset the digestive system. Depending on the treatment plan, Ondansetron may be advised to ease these symptoms.\n\n3. Post-operative nausea and vomiting\nAnaesthesia and other factors around surgery can leave patients feeling sick. Ondansetron may be used to prevent or manage this and make recovery more comfortable.\n\n4. Other situations at the doctor’s discretion\nIn some cases, a physician may consider Ondansetron for serotonin-related nausea and vomiting, based on the patient’s condition and prescribing guidelines.\n\nHow It Works\n\nSerotonin is a natural chemical messenger that helps regulate digestion, among other functions. Chemotherapy and similar treatments can cause a sudden release of serotonin in the gut. It then binds to 5-HT3 receptors on the stomach and intestinal lining and on the vagus nerve, which carries a “feel sick” message to the vomiting centre in the brain.\n\nOndansetron works by:\n\nOccupying and blocking 5-HT3 receptors\nCutting down the nausea signals sent to the brain\nKeeping the vomiting reflex from being triggered\nOffering dependable antiemetic cover where treatment is clinically needed\nKey Highlights\n8 mg Ondansetron IP in every tablet\nOrally disintegrating (mouth-dissolving) format\nA selective 5-HT3 receptor antagonist\nPrescribed for specific types of nausea and vomiting\nDissolves in the mouth, so no whole-tablet swallowing is needed\nSuited to chemotherapy, radiotherapy and post-surgical care\nPart of the Steris Pharma product range\nBenefits of Ondansetron 8 mg Mouth-Dissolving Tablets\n\nWhen prescribed for the right reason, patients and doctors may value the following:\n\nEffective symptom control: Targets the serotonin pathway behind vomiting.\nEasy to take: Melts on the tongue, which is handy when swallowing is uncomfortable.\nProven track record: A widely used antiemetic in oncology and surgical settings.\nSupport during cancer care: Helps patients stay more comfortable through demanding treatment cycles.\nFlexible dosing format: An alternative to standard swallowed tablets, subject to the product’s instructions.\nSmoother recovery: Can reduce sickness after surgery when clinically appropriate.\nHow to Use ONDEFILM 8 DT\n\nFollow your doctor’s prescription. The regimen depends on why the medicine is needed, your age, your medical history and other factors.\n\nGeneral steps:\n\nWash and thoroughly dry your hands.\nOpen the blister pack carefully as per the pack instructions.\nTake the tablet out gently so it does not crumble.\nPlace it on your tongue and let it dissolve.\nFollow the product leaflet on swallowing once it has dissolved.\nDo not take extra tablets unless your doctor tells you to.\nPossible Side Effects\n\nSome people may notice:\n\nHeadache\nConstipation\nLoose stools\nDizziness\nTiredness\nA general feeling of being unwell\n\nSeek medical help immediately if you experience:\n\nA fast, uneven or fluttering heartbeat\nQT prolongation (a heart-rhythm change)\nSigns of a serious allergy\nFainting or blackouts\nSymptoms of serotonin syndrome, especially if you also take other serotonin-raising medicines\nPrecautions and Safety Advice\n\nTell your doctor about your health history and everything you currently take before starting this medicine.\n\nAllergy: Do not use it if you are allergic to Ondansetron or any ingredient in the tablet.\nHeart problems: Mention any rhythm disorder, congenital long QT syndrome or past cardiac issues.\nElectrolytes: Low potassium or magnesium can raise the risk of rhythm problems and may need to be corrected or monitored.\nLiver disease: A dose adjustment may be needed for reduced liver function.\nOther medicines: Share details of prescription drugs, over-the-counter products and supplements.\nSerotonergic drugs: Combining them with Ondansetron may increase the chance of serotonin syndrome.\nPregnancy and breastfeeding: Use only after medical evaluation and advice.\nDose: Never take more, or more often, than prescribed.\nWhy Steris Pharma?\n\nSteris Pharma develops a broad portfolio of medicines for varied therapeutic needs, with an emphasis on consistent quality, product reliability and the evolving expectations of doctors, distributors and patients. ONDEFILM 8 DT is part of this range as a convenient Ondansetron 8 mg mouth-dissolving option for patients who need antiemetic therapy under medical supervision.\n\nConclusion\n\nONDEFILM 8 DT delivers Ondansetron IP 8 mg in a tablet that dissolves in the mouth. It is used to prevent and treat nausea and vomiting arising from chemotherapy, radiotherapy and surgery. By blocking 5-HT3 receptors, it stops the signals that trigger vomiting, and its easy-to-take format suits patients who struggle with conventional tablets. Always use it under a doctor’s guidance.\n\nFrequently Asked Questions\n\nQ1. What is ONDEFILM 8 DT prescribed for?\nIt is prescribed to prevent and control nausea and vomiting caused by treatments such as chemotherapy, radiotherapy and surgery.\n\nQ2. What does each tablet contain?\nEach tablet has 8 mg of Ondansetron IP plus approved excipients.\n\nQ3. What is Ondansetron 8 mg used for?\nIt is an anti-sickness medicine used to prevent or relieve nausea and vomiting when a doctor considers it appropriate.\n\nQ4. What does “DT” stand for?\nDT means Disintegrating Tablet, a tablet that breaks down in the mouth instead of being swallowed whole.\n\nQ5. How does this medicine work?\nIt blocks 5-HT3 serotonin receptors, so the nausea and vomiting signals do not reach the brain.\n\nQ6. Is it an antiemetic?\nYes. Ondansetron belongs to the 5-HT3 receptor antagonist group of antiemetics.\n\nQ7. Does it help with chemotherapy-induced vomiting?\nYes. It is widely included in treatment plans to prevent chemotherapy-induced nausea and vomiting.\n\nQ8. Is it used after surgery?\nIt may be, to prevent or manage post-operative nausea and vomiting, depending on the doctor’s assessment.\n\nQ9. Can I buy it without a prescription?\nNo. It must be used only on the advice of a qualified healthcare professional.\n\nQ10. How do I take it?\nPlace the tablet on your tongue and let it dissolve, following the pack instructions and your doctor’s advice.",
"price": 97.0,
"discountamount": 29.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2513,
"imageuri": "https://productimages.withfloats.com/actual/6afd8129a836274a90032451.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6afd8129a836274a90032451.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-11-18T10:42:45.31Z",
"updatedon": "2026-11-18T10:42:45.31Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//ondansetron-8-mg-orally-disintegrating-tablets-ip/2513",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ONDEFILM 8 DT",
"category": "Gastrology",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6afd7dd19d17e024ee47e07c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Ondansetron 4 mg Orally Disintegrating Tablets IP",
"description": "Product Overview\n\nONDEFILM 4 is an antiemetic medicine that provides 4 mg of Ondansetron IP in an orally disintegrating tablet. It is used to prevent and relieve nausea and vomiting linked to certain medical treatments and clinical situations, as advised by a healthcare professional.\n\nIts active ingredient, Ondansetron, is a selective 5-HT3 receptor antagonist. It stops serotonin from triggering the receptors that set off the body’s vomiting reflex, which lowers the signals behind nausea and vomiting.\n\nComposition\n\nEach orally disintegrating tablet contains:\n\nOndansetron IP: 4 mg\nExcipients: As per the approved product formulation\nAbout Ondansetron\n\nOndansetron is a widely used 5-HT3 receptor antagonist in clinical practice. Doctors rely on it to prevent and manage nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. It works by interrupting the serotonin-driven signals that activate the vomiting reflex.\n\nWhat Is ONDEFILM 4 Used For?\n\nONDEFILM 4 is prescribed in specific situations where nausea and vomiting need to be prevented or kept under control, especially in supportive care.\n\n1. Chemotherapy-induced nausea and vomiting\nSome cancer medicines cause the gut to release serotonin, which brings on nausea and vomiting. Ondansetron blocks 5-HT3 receptors to help prevent this and is included in standard antiemetic protocols for chemotherapy.\n\n2. Radiation therapy-related vomiting\nDepending on the area treated and the radiation schedule, radiotherapy can cause nausea and vomiting. Ondansetron may be advised to ease these symptoms when appropriate.\n\n3. Postoperative nausea and vomiting\nAnaesthesia and other factors around surgery can leave some patients feeling sick afterwards. Ondansetron is used in suitable cases to prevent or treat this.\n\n4. Other medically indicated uses\nDoctors may also consider Ondansetron in selected situations of nausea and vomiting, depending on the cause and current treatment guidance.\n\nThe treating physician decides the dose and duration based on the patient’s history and treatment needs.\n\nHow Does ONDEFILM 4 Work?\n\nSerotonin is a natural chemical messenger that helps regulate digestion and the vomiting reflex. During some treatments, the body releases extra serotonin, which activates 5-HT3 receptors in the gut and in nerve pathways leading to the brain. This sends the signals that cause nausea and vomiting.\n\nMechanism of action:\n\nOndansetron attaches to 5-HT3 receptors and blocks them.\nThis reduces serotonin’s stimulation of the related nerve pathways.\nThe signals that trigger the vomiting reflex are interrupted.\nAs a result, nausea and vomiting are prevented or controlled.\nKey Features\n4 mg of Ondansetron IP in every tablet\nOrally disintegrating form that dissolves in the mouth\nBelongs to the selective 5-HT3 receptor antagonist class\nMeant for preventing and managing nausea and vomiting\nA different option from tablets that must be swallowed whole\nUsed in medical and supportive care settings\nPart of the Steris Pharma product range\nBenefits of Ondansetron 4 mg Orally Disintegrating Tablets\n\nWhen taken as medically advised, Ondansetron 4 mg offers these advantages:\n\nEases nausea and vomiting: It acts on the serotonin receptors involved in the vomiting response.\nDissolves in the mouth: The tablet breaks down on the tongue, which can help patients who find swallowing regular tablets hard.\nProven mechanism: Ondansetron has a long-standing place in antiemetic therapy, including chemotherapy and postoperative care.\nSimple to take: The mouth-dissolving format gives selected patients a more convenient way to take their dose.\nSupports patients during treatment: Controlling nausea and vomiting can make certain treatments and procedures easier to get through.\nTargeted action: It works on a specific serotonin pathway that plays a major role in nausea and vomiting.\nHow to Take ONDEFILM 4\n\nGeneral guidance for orally disintegrating tablets:\n\nWash and dry your hands before touching the tablet.\nOpen the pack carefully as the instructions describe.\nTake the tablet out gently, without crushing or breaking it.\nPlace it on your tongue and let it dissolve.\nFollow the product instructions on swallowing once it has dissolved.\nDo not take more than the prescribed amount.\nIf you miss a dose, ask your healthcare professional what to do next. Never double the next dose to make up for it.\nPossible Side Effects\n\nOndansetron can cause unwanted effects in some people, and how often and how strongly they occur differs from patient to patient.\n\nCommonly reported:\n\nHeadache\nConstipation\nDiarrhoea\nDizziness\nTiredness\n\nPotentially serious reactions:\n\nOndansetron may rarely cause QT interval prolongation, irregular heart rhythms, and severe allergic reactions. Serotonin syndrome can also occur, particularly when it is taken with other medicines that raise serotonin activity.\n\nGet medical help straight away if you experience fainting, an unusual heartbeat, difficulty breathing, swelling of the face, severe dizziness, or any other worrying symptom.\n\nPrecautions and Safety Information\n\nBefore starting ONDEFILM 4, give your doctor your full medical history and a list of the medicines you take.\n\nAllergies: Do not use it if you are allergic to Ondansetron or any ingredient in the tablet.\nHeart rhythm problems: Tell your doctor about any past arrhythmia, QT prolongation, or congenital long QT syndrome.\nElectrolyte imbalance: Low potassium or magnesium raises the chance of heart rhythm complications.\nLiver conditions: Patients with significant liver impairment may need special care and a dose adjustment.\nDrug interactions: Mention all prescription medicines, over-the-counter products, and supplements.\nSerotonin syndrome risk: Let your doctor know if you take antidepressants or other medicines that act on serotonin.\nPregnancy and breastfeeding: Use it only after your doctor has weighed the benefits against the risks.\nDosage: Stick to the prescribed schedule and do not take extra doses without medical advice.\nWhy Choose Steris Pharma?\n\nSteris Pharma offers a range of medicines and healthcare formulations covering varied therapeutic needs. The company focuses on pharmaceutical quality, product reliability, and the requirements of healthcare professionals and patients.\n\nONDEFILM 4 belongs to this range and offers Ondansetron 4 mg as an orally disintegrating tablet, giving patients who need antiemetic treatment another dosage option under professional guidance.\n\nConclusion\n\nONDEFILM 4 is an Ondansetron 4 mg orally disintegrating tablet used to prevent and manage nausea and vomiting tied to specific treatments and clinical situations. Its active ingredient blocks the serotonin 5-HT3 receptors that drive the vomiting response. Because the tablet dissolves in the mouth, it can also be a handy alternative for people who struggle to swallow conventional tablets.\n\nFrequently Asked Questions (FAQs)\n\nQ1. What is ONDEFILM 4 used for?\nIt is used to prevent and manage nausea and vomiting linked to chemotherapy, radiotherapy, and surgery, as prescribed by a healthcare professional.\n\nQ2. What does ONDEFILM 4 contain?\nEach tablet has 4 mg of Ondansetron IP plus the excipients listed in the approved formulation.\n\nQ3. What is Ondansetron 4 mg used for?\nIt is an antiemetic prescribed to prevent or control nausea and vomiting in suitable clinical situations.\n\nQ4. What kind of medicine is ONDEFILM 4?\nIt is a selective serotonin 5-HT3 receptor antagonist, a class of medicines used against nausea and vomiting.\n\nQ5. How does ONDEFILM 4 stop vomiting?\nIt blocks the 5-HT3 receptors that pass on the signals triggering the vomiting reflex, which reduces nausea and vomiting.\n\nQ6. What does DT mean in ONDEFILM 4?\nDT stands for disintegrating tablet, a form made to break down in the mouth rather than be swallowed whole.\n\nQ7. Can ONDEFILM 4 help with chemotherapy-induced nausea?\nYes. Ondansetron is a common part of antiemetic protocols for preventing chemotherapy-related nausea and vomiting.\n\nQ8. Is Ondansetron 4 mg used after surgery?\nYes. Doctors may prescribe it to prevent or treat postoperative nausea and vomiting, depending on the patient’s needs.\n\nQ9. Can I take ONDEFILM 4 without a doctor’s advice?\nNo. Use it only as directed by a qualified healthcare professional.\n\nQ10. How do I take ONDEFILM 4?\nPlace the tablet on your tongue and let it dissolve, following the instructions that come with the product.\n\nQ11. What are the common side effects of ONDEFILM 4?\nThey include headache, constipation, diarrhoea, dizziness, and tiredness.\n\nQ12. Can ONDEFILM 4 affect the heart’s rhythm?\nIn some people, Ondansetron can prolong the QT interval. Anyone with a heart rhythm disorder or electrolyte imbalance should talk to their doctor first.\n\nQ13. Is ONDEFILM 4 suitable if I have trouble swallowing?\nThe mouth-dissolving form can be a convenient alternative to regular tablets for some patients, subject to medical advice and the product instructions.\n\nQ14. Can I use Ondansetron 4 mg during pregnancy?\nConsult your doctor first. The decision depends on an individual assessment of benefits and risks.\n\nQ15. Does ONDEFILM 4 cause constipation?\nYes. Constipation is a recognised side effect and may affect some patients.\n\nQ16. Can ONDEFILM 4 be used for motion sickness?\nOndansetron is not usually a first-choice treatment for motion sickness. The right medicine depends on the cause of the nausea, so ask a healthcare professional.\n\nQ17. Who markets ONDEFILM 4?\nIt is marketed under the Steris Pharma brand.\n\nQ18. Is ONDEFILM 4 an antibiotic?\nNo. It is an antiemetic for nausea and vomiting and does not treat bacterial infections.",
"price": 55.0,
"discountamount": 16.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2512,
"imageuri": "https://productimages.withfloats.com/actual/6afd7e24e81314fd1baff0a1.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6afd7e24e81314fd1baff0a1.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-11-18T10:28:33.741Z",
"updatedon": "2026-11-18T10:29:51.37Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//ondansetron-4-mg-orally-disintegrating-tablets-ip/2512",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ONDEFILM 4",
"category": "GASTROLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6abe4471401ae1a1106d67d9",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Bisoprolol 1.25mg",
"description": "Bisoprolol 1.25mg is the smallest tablet strength of bisoprolol, a heart-selective beta-1 blocker. Doctors usually prescribe it to start treatment or to build up the dose gradually in people with high blood pressure, chronic stable heart failure, or fast heart rhythms. It suits older adults, people with mild heart failure, and anyone who reacts strongly to beta-blockers. The medicine slows the heartbeat and eases the force of each contraction, so the heart works less hard. BISOGARD 1.25 from Steris Healthcare Pvt. Ltd. comes in a strip pack of 15 tablets. It is a Schedule H medicine, so it must only be started, changed, or stopped on a doctor's advice.\n\nProduct Snapshot\n\nBrand: BISOGARD 1.25\nManufacturer/Marketer: Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company in India\nActive ingredient: Bisoprolol Fumarate 1.25mg\nForm: Tablet\nPack size: 15 tablets\nDrug class: Cardioselective beta-1 blocker\nLegal status: Schedule H (valid prescription required)\nAvailability: Through Steris Healthcare's authorized pharmacies and its B2B PCD franchise network across India\nWhat Is Bisoprolol 1.25mg?\n\nIf your doctor has just prescribed bisoprolol 1.25mg, you have been given the lowest dose on purpose. Bisoprolol is a cardioselective beta-1 blocker, meaning it acts mostly on receptors in the heart and has much less effect on the lungs and blood vessels. This is a major reason it is preferred over older, non-selective beta-blockers, especially for people who also have a mild breathing problem.\n\nThe 1.25mg tablet is not a “light” medicine for mild illness. It is a carefully chosen entry point. In heart failure, a weakened heart can struggle if its rate or pressure drops too quickly, so cardiologists follow a “start low, go slow” approach. Treatment begins at 1.25mg, the response is watched for one to two weeks, and the dose is raised step by step (commonly 2.5mg, 3.75mg, 5mg, 7.5mg, and up to 10mg) as the heart adapts. That is why BISOGARD 1.25 is often the first tablet a newly diagnosed heart failure patient takes.\n\nWhat Is Bisoprolol 1.25mg Used For?\n\nDoctors commonly prescribe this strength for:\n\nChronic heart failure (HFrEF): as the first step of dose titration in patients with a reduced ejection fraction, alongside ACE inhibitors/ARBs and diuretics\nHigh blood pressure: especially in older adults, people with low body weight, and those who are sensitive to blood-pressure-lowering drugs\nStable angina: to reduce the heart's oxygen demand and relieve chest discomfort\nAfter a heart attack: in selected patients, under a cardiologist's care\nHeart rate control in some arrhythmias: sometimes used off-label at a low dose to gently bring down a fast heart rate\n\nAt 1.25mg, bisoprolol is seldom meant as the long-term sole treatment for high blood pressure in an otherwise healthy adult. It is usually the first rung of a titration ladder, or a steady maintenance dose for patients who are unusually beta-blocker sensitive (older age, low body weight, or borderline low pressure or pulse).\n\nHow Does Bisoprolol Work?\n\nBisoprolol selectively blocks beta-1 adrenergic receptors, which are packed mainly into heart muscle. This leads to several effects:\n\nSlower heart rate: the heart has more time to fill and rest between beats\nGentler contractions: the heart muscle needs less oxygen and energy\nLess renin from the kidneys: this helps blood pressure fall gradually over time\nLower overall cardiac workload: a real advantage for a heart that already struggles to pump well, as in heart failure\nKey Benefits of BISOGARD 1.25\nA gentle starting dose, well suited to careful titration in frail or elderly patients\nHeart-focused action, with less effect on the lungs and peripheral blood vessels than non-selective beta-blockers\nOnce-daily dosing, which makes it easier to stay on treatment\nA guideline-recommended beta-blocker for HFrEF with well-established outcomes data [Reviewer note: insert specific outcome statistics/trial citation pending medical sign-off]\nMade by Steris Healthcare Pvt. Ltd. under WHO-GMP and ISO-certified standards\nDosage Guidance\nUsual starting dose (heart failure): 1.25mg once a day, preferably in the morning\nDose increases: typically every 1–2 weeks (2.5mg, 3.75mg, 5mg, 7.5mg, up to a maximum of 10mg daily), depending on how well you tolerate it and on your pulse and blood pressure\nHigh blood pressure (sensitive patients): 1.25mg to 5mg once daily, as set by your doctor\nHow to take it: at the same time every day, with or without food, swallowed whole with water\nIf you miss a dose: take it when you remember, unless the next dose is almost due. Never take a double dose.\nNever stop suddenly: abrupt withdrawal can cause a rebound rise in heart rate, blood pressure, or chest pain. The dose must be reduced gradually under medical supervision.\nIs It Better to Take Bisoprolol in the Morning or at Night?\n\nMost doctors advise a morning dose. Bisoprolol lowers pulse and blood pressure, and taking it early matches its action to your daytime activity. A night-time dose could add to the body's natural overnight dip in blood pressure and raise the chance of dizziness when getting up in the dark. Some people who feel tired during the day are told by their doctor to switch to the evening. Do not change your dosing time without your doctor's approval.\n\nSide Effects of Bisoprolol 1.25mg\n\nCommon side effects\n\nTiredness or fatigue\nDizziness or light-headedness, especially on standing quickly\nCold hands or feet\nSlow pulse (bradycardia)\nHeadache\nMild stomach upset (nausea, loose stools)\nDisturbed sleep\n\nSerious side effects (get medical help promptly)\n\nVery slow heartbeat or fainting\nIncreasing breathlessness or swollen legs/ankles, which may mean heart failure is worsening\nAllergic reaction: rash, swelling of the face or throat, trouble breathing\nCold, numb, or bluish fingers and toes\nWheezing or new breathing difficulty, particularly in people with asthma or COPD\nMood changes, low mood, or confusion\nWhat Are the Bad Side Effects of Bisoprolol?\n\nThe effects that need urgent attention are a dangerously slow pulse, fainting, signs of worsening heart failure (swelling, breathlessness), severe allergic reactions, and airway tightening in people with lung disease. These are uncommon at the 1.25mg dose, but anyone who notices them should seek medical help right away. [Reviewer note: specific incidence rates pending clinical/medical sign-off]\n\nSubstitutes & Comparable Beta-Blockers\nMolecule\tSelectivity\tTypical Use Case\nBisoprolol\tHighly cardioselective\tHeart failure titration, hypertension\nMetoprolol Succinate ER\tCardioselective\tHypertension, angina, heart failure\nAtenolol\tCardioselective (older agent)\tHypertension\nCarvedilol\tNon-selective with alpha-blocking action\tHeart failure (adds vasodilation)\nPropranolol\tNon-selective\tMigraine prevention, anxiety-related fast heartbeat, essential tremor\nPrecautions & Who Should Avoid Bisoprolol\nNot suitable for people with severe bradycardia, certain forms of heart block (unless a pacemaker is fitted), unstable or acutely decompensated heart failure, or severe uncontrolled asthma\nUse carefully in diabetes, because beta-blockers can hide the warning signs of low blood sugar\nTake care in peripheral vascular disease, as cold extremities or leg pain on walking may worsen\nNever stop it abruptly; always taper under a doctor's guidance\nTell your doctor about every medicine you use, especially other blood-pressure drugs, calcium channel blockers, and certain antiarrhythmics\nIn pregnancy and breastfeeding, use only if your doctor advises it after weighing benefits and risks\nIs Bisoprolol Safe for Kidneys?\n\nThe body clears bisoprolol through both the liver and the kidneys in roughly equal measure. It is generally considered safe for people with normal or mildly reduced kidney function. When kidney impairment is significant, drug levels in the blood can rise, so your doctor may lower the dose or monitor you more closely. Always tell your prescriber about any kidney disease before starting.\n\nIs Bisoprolol a High-Risk Medication?\n\nBisoprolol is not a narrow therapeutic index drug like tacrolimus or warfarin, where small dose differences matter greatly. Even so, it needs supervised use because it directly affects heart rate and blood pressure. The main dangers are stopping it suddenly, which can set off rebound cardiac events, and using it with certain existing rhythm disorders. Taken as prescribed and checked regularly, it has a long and reassuring safety record.\n\nDoes 1.25mg Bisoprolol Lower Blood Pressure?\n\nYes. Even the smallest dose measurably reduces heart rate and blood pressure by lightening the heart's workload and reducing renin-driven narrowing of blood vessels. At this strength the effect on blood pressure is fairly mild, which is exactly why it is a safe place to begin, especially for older adults or people starting heart failure treatment. The dose is then raised gradually to reach full benefit.\n\nFrequently Asked Questions\n\n1. What is 1.25 mg of bisoprolol used for?\nMainly as a low starting dose when building up treatment for chronic heart failure, and for high blood pressure in people who are very sensitive to beta-blockers, such as older adults.\n\n2. What are the bad side effects of bisoprolol?\nThe more serious ones are a very slow pulse, fainting, worsening heart failure signs (swelling, breathlessness), severe allergy, and breathing trouble in people with lung conditions.\n\n3. What are the common side effects of bisoprolol fumarate 1.25 mg tablets?\nTiredness, dizziness, cold hands and feet, mild headache, and a slightly slower pulse.\n\n4. Is it better to take bisoprolol in the morning or at night?\nMorning is usually preferred so its effect fits daytime activity, though your doctor may suggest evenings in some cases.\n\n5. What is the cost of bisoprolol?\nPrice depends on strength, pack size, and brand. Use the “Check Price” option above for current BISOGARD 1.25 pricing from Steris Healthcare.\n\n6. Does 1.25 mg bisoprolol lower blood pressure?\nYes, though only modestly at this dose. The dose is often stepped up over time.\n\n7. Is bisoprolol safe for kidneys?\nGenerally yes for normal or mildly reduced kidney function. People with significant kidney impairment need dose adjustment and monitoring.\n\n8. Is bisoprolol a high-risk medication?\nIt is not a narrow therapeutic index drug, but it must never be stopped suddenly and should be used under medical supervision because of its direct effect on the heart.\n\n9. Can I take bisoprolol 1.25mg for the rest of my life?\nMany people with chronic heart failure or hypertension do take bisoprolol long term, but the dose usually rises as tolerated. Your doctor should review it regularly.\n\n10. What happens if I miss a dose of bisoprolol?\nTake it when you remember, unless the next dose is nearly due. In that case skip the missed one. Never take two together.\n\n11. Can bisoprolol 1.25mg cause weight gain?\nIt is not commonly reported at this dose. Fluid retention linked to heart failure itself should be reported to your doctor.\n\n12. Is bisoprolol safe for diabetic patients?\nIt can be used, with care, because beta-blockers may hide warning signs of low blood sugar such as a racing heartbeat.\n\n13. Can I stop taking bisoprolol suddenly if I feel fine?\nNo. Stopping abruptly can cause a rebound rise in heart rate, blood pressure, or chest pain. Reduce the dose gradually under medical guidance.\n\n14. Does bisoprolol interact with other blood pressure medicines?\nYes. Combining it with other drugs that lower heart rate or pressure (such as calcium channel blockers) can cause a very low pulse or pressure. Tell your doctor about all your medicines.\n\n15. Is BISOGARD 1.25 available without a prescription?\nNo. Bisoprolol is a Schedule H medicine in India and needs a valid prescription.\n\n16. How long does it take for bisoprolol 1.25mg to start working?\nSome effect on heart rate appears within hours, but the full benefit for blood pressure or heart failure symptoms builds over several weeks of regular use.\n\n17. Can pregnant women take bisoprolol?\nOnly if clearly necessary and prescribed by a doctor, as it may affect the baby's heart rate and growth.",
"price": 39.0,
"discountamount": 12.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2501,
"imageuri": "https://productimages.withfloats.com/actual/6abe4474c205678e0b16a23a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6abe4474c205678e0b16a23a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-01T11:30:57.88Z",
"updatedon": "2026-10-01T11:30:57.88Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//bisoprolol-1-25mg/2501",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Bisogard 1.25",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a952bdada41ea9aeeec5e4a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Semaglutide injection 8 mg",
"description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.",
"price": 7800.0,
"discountamount": 2340.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2498,
"imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-31T07:23:06.814Z",
"updatedon": "2026-08-31T07:23:06.814Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SAMIGLUTIDE 8MG",
"category": "DIABETIC RANGE",
"tags": [
"Semaglutide injection 8 mg",
"semaglutide injection 8 mg",
"semaglutide 8 mg injection uses",
"semaglutide 8 mg injection benefits",
"semaglutide 8 mg injection dosage"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a8c3838c90065ecdc86c757",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Semaglutide Injection 4mg",
"description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.",
"price": 6600.0,
"discountamount": 1980.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2497,
"imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-24T12:25:28.659Z",
"updatedon": "2026-08-24T12:25:28.659Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SAMIGLUTIDE 4 MG",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a8c35e76d1f6b0cbc0e2e40",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Semaglutide Injection 2 mg",
"description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.",
"price": 5600.0,
"discountamount": 1680.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2496,
"imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-24T12:15:35.873Z",
"updatedon": "2026-08-24T12:15:35.873Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-2-mg/2496",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SAMIGLUTIDE 2 MG",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a6def248b0777b5cb29791c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Propranolol Hydrochloride Sustained Release Capsules IP",
"description": "PROPASULES LA 40 is a premium pharmaceutical formulation containing Propranolol Hydrochloride Sustained Release Capsules IP 40 mg. Developed with advanced sustained-release technology, this formulation delivers the active ingredient gradually over an extended period, helping maintain consistent therapeutic levels while supporting the convenience of once-daily administration when prescribed by a healthcare professional.\n\nManufactured in GMP-certified facilities using pharmaceutical-grade raw materials, PROPASULES LA 40 is produced under strict quality control measures to ensure purity, safety, and batch-to-batch consistency. It is intended for the treatment of medical conditions in which propranolol therapy is considered appropriate by a qualified physician.\n\nComposition\n\nEach Sustained Release Capsule Contains:\n\nPropranolol Hydrochloride IP – 40 mg\nSustained Release Pellets\nPharmaceutical Excipients – q.s.\nCapsule Shell – Approved pharmaceutical-grade ingredients\n\nDosage Form: Sustained Release Capsules\n\nWhat is PROPASULES LA 40?\n\nPROPASULES LA 40 contains Propranolol Hydrochloride, a non-selective beta-adrenergic receptor blocker (beta-blocker) that helps manage a variety of cardiovascular and neurological conditions. The sustained-release formulation is specifically designed to release the medicine gradually throughout the day, providing prolonged therapeutic action and helping maintain stable plasma drug concentrations compared with conventional immediate-release formulations.\n\nIts controlled-release technology enhances dosing convenience and supports consistent treatment outcomes when used according to medical advice.\n\nKey Features\nContains Propranolol Hydrochloride Sustained Release IP 40 mg\nAdvanced sustained-release technology for prolonged drug delivery\nSupports once-daily dosing as prescribed\nManufactured using premium pharmaceutical-grade ingredients\nProduced in GMP-compliant manufacturing facilities\nStringent quality assurance for consistent product performance\nReliable formulation for long-term therapeutic use under medical supervision\nTherapeutic Uses\n\nHealthcare professionals may prescribe PROPASULES LA 40 for the management of several cardiovascular and neurological disorders, including:\n\nHypertension (high blood pressure)\nChronic stable angina\nCardiac arrhythmias\nPrevention of migraine attacks\nEssential tremor\nPhysical symptoms associated with anxiety\nCardiovascular manifestations of hyperthyroidism\nSecondary prevention following myocardial infarction, when clinically indicated\n\nThe choice of treatment, dosage, and duration should always be individualized based on the patient's medical condition and physician's assessment.\n\nHow PROPASULES LA 40 Works\n\nPropranolol Hydrochloride works by blocking beta-adrenergic receptors located in the heart and other tissues. This action reduces the effects of adrenaline and other stress hormones on the cardiovascular system.\n\nAs a result, the medicine may help:\n\nSlow the heart rate\nReduce the workload on the heart\nLower elevated blood pressure\nImprove control of certain abnormal heart rhythms\nReduce the frequency of migraine episodes\nMinimize symptoms associated with essential tremor\nRelieve physical manifestations of anxiety, such as rapid heartbeat and trembling\n\nThe sustained-release pellets gradually release the medication throughout the day, providing prolonged therapeutic coverage and reducing fluctuations in drug levels.\n\nBenefits of the Sustained Release Formulation\n\nThe advanced sustained-release technology offers several advantages:\n\nControlled and gradual release of the active ingredient\nExtended therapeutic effect throughout the dosing interval\nMore consistent blood concentrations of the medication\nReduced peak-to-trough fluctuations compared with immediate-release formulations\nConvenient dosing schedule that may improve treatment adherence\nSuitable for long-term therapy under medical supervision\n\nTreatment outcomes depend on individual patient response and adherence to the prescribed regimen.\n\nDosage and Administration\n\nTake PROPASULES LA 40 exactly as instructed by your healthcare provider.\n\nGeneral recommendations include:\n\nSwallow the capsule whole with sufficient water.\nDo not crush, chew, or open the capsule unless specifically advised.\nTake the medicine at the same time every day.\nFollow the prescribed dosage schedule carefully.\nDo not discontinue treatment abruptly without consulting your physician, as sudden withdrawal may increase the risk of cardiovascular complications.\nPossible Side Effects\n\nLike all medications, PROPASULES LA 40 may cause side effects in some individuals, although many patients tolerate it well.\n\nCommon side effects may include:\n\nFatigue\nDizziness\nSlow heartbeat\nCold hands and feet\nNausea\nSleep disturbances\nMild stomach discomfort\n\nSeek immediate medical attention if you experience breathing difficulty, severe dizziness, fainting, swelling of the face or throat, or signs of a serious allergic reaction.\n\nConsult your healthcare provider if any side effects persist or become troublesome.\n\nPrecautions and Warnings\n\nBefore starting PROPASULES LA 40, inform your doctor if you have:\n\nAsthma or chronic obstructive pulmonary disease (COPD)\nDiabetes mellitus\nLiver impairment\nKidney disease\nHeart failure\nLow blood pressure\nBradycardia (slow heart rate)\nPeripheral vascular disease\nThyroid disorders\nHistory of hypersensitivity reactions\n\nYour physician should also be informed about all prescription medicines, over-the-counter drugs, herbal supplements, and dietary products you are taking to minimize the risk of drug interactions.\n\nPregnancy and Breastfeeding\n\nThe use of PROPASULES LA 40 during pregnancy or breastfeeding should only be considered when recommended by a qualified healthcare professional after carefully evaluating the potential benefits and possible risks.\n\nAlways consult your physician before taking this medicine during pregnancy or while nursing.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from moisture and direct sunlight.\nKeep below the storage temperature specified on the product label.\nStore in the original packaging until use.\nKeep out of the reach of children.\nDo not use the medicine after the expiry date printed on the pack.\nWhy Choose PROPASULES LA 40?\n\nPROPASULES LA 40 is formulated to deliver dependable therapeutic performance through advanced sustained-release technology. Manufactured under stringent pharmaceutical quality standards, it combines consistent drug delivery, convenient dosing, and reliable product quality to support long-term cardiovascular and neurological care.\n\nKey Advantages\n\nPremium sustained-release Propranolol formulation\nControlled drug release for prolonged therapeutic action\nConvenient once-daily administration as prescribed\nManufactured in GMP-certified facilities\nHigh standards of quality, purity, and consistency\nReliable formulation for chronic disease management\nFrequently Asked Questions (FAQs)\nWhat is PROPASULES LA 40 prescribed for?\n\nPROPASULES LA 40 may be prescribed for conditions such as hypertension, chronic angina, cardiac arrhythmias, migraine prevention, essential tremor, anxiety-related physical symptoms, and certain cardiovascular conditions, depending on the physician's evaluation.\n\nCan PROPASULES LA 40 be taken once a day?\n\nYes. The sustained-release formulation is designed to support convenient once-daily dosing when prescribed by a healthcare professional.\n\nCan I stop taking PROPASULES LA 40 suddenly?\n\nNo. Abrupt discontinuation of propranolol may increase the risk of serious cardiovascular events. Always consult your doctor before stopping treatment.\n\nCan people with diabetes take PROPASULES LA 40?\n\nPatients with diabetes should use this medicine only under medical supervision, as beta-blockers may mask some warning signs of low blood sugar.\n\nIs PROPASULES LA 40 suitable for every patient?\n\nNo. This medicine may not be appropriate for individuals with certain conditions such as severe asthma, significant bradycardia, or specific cardiac disorders. Your healthcare provider will determine whether it is suitable for your individual medical needs.",
"price": 45.0,
"discountamount": 14.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2490,
"imageuri": "https://productimages.withfloats.com/actual/6a6def271f223d84dee2d962.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a6def271f223d84dee2d962.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-01T13:05:40.676Z",
"updatedon": "2026-08-01T13:05:40.676Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//propranolol-hydrochloride-sustained-release-capsules-ip/2490",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PROPASULES LA 40",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}